PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 224 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $1,105,000 | -8.7% | 154,976 | +205.9% | 0.03% | +300.0% |
Q4 2019 | $1,210,000 | +490.2% | 50,655 | +382.4% | 0.01% | +250.0% |
Q4 2018 | $205,000 | -57.7% | 10,501 | +17.0% | 0.00% | -77.8% |
Q3 2017 | $485,000 | -24.0% | 8,978 | -27.6% | 0.01% | -87.1% |
Q4 2015 | $638,000 | – | 12,400 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Grace Capital | 270,832 | $6,467,000 | 5.27% |
Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |